Rethinking the therapeutic pyramid for rheumatoid arthritis: When are NSAIDs alone not enough?: Postgraduate Medicine: Vol 91, No 2

Views

CrossRef citations to date

Altmetric

Preview

Many physicians are reluctant to prescribe agents other than nonsteroidal anti-inflammatory drugs (NSAIDs) early in the course of rheumatoid arthritis. Yet some of those agents, unlike NSAIDs, can actually modify the disease, and they may be less toxic than NSAIDs. The authors discuss when and how they use gold salts, penicillamine, corticosteroids, immunosuppressive drugs, and antimalarial agents in the treatment of rheumatoid arthritis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Rethinking the therapeutic pyramid for rheumatoid arthritis

When are NSAIDs alone not enough?

Information for

Open access

Opportunities

Help and information

Rethinking the therapeutic pyramid for rheumatoid arthritis

When are NSAIDs alone not enough?

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature